558 related articles for article (PubMed ID: 16961441)
1. Effect of generic-only drug benefits on seniors' medication use and financial burden.
Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
[TBL] [Abstract][Full Text] [Related]
2. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
Fischer MA; Avorn J
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
[TBL] [Abstract][Full Text] [Related]
3. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
4. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
Federman AD; Halm EA; Siu AL
Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
[TBL] [Abstract][Full Text] [Related]
5. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
6. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
7. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
Kong Y
Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
[TBL] [Abstract][Full Text] [Related]
8. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
9. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT
Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812
[TBL] [Abstract][Full Text] [Related]
10. Dispensing pattern of generic and brand-name drugs in children.
Chen AY; Wu S
Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
[TBL] [Abstract][Full Text] [Related]
11. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
Rodin HA; Heaton AH; Wilson AR; Garrett NA; Plocher DW
Am J Manag Care; 2009 Dec; 15(12):881-8. PubMed ID: 20001169
[TBL] [Abstract][Full Text] [Related]
12. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
[TBL] [Abstract][Full Text] [Related]
13. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
Layton S; Barbeau M
Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
[TBL] [Abstract][Full Text] [Related]
14. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
[TBL] [Abstract][Full Text] [Related]
15. The relationship between older adults' knowledge of their drug coverage and medication cost problems.
Piette JD; Heisler M
J Am Geriatr Soc; 2006 Jan; 54(1):91-6. PubMed ID: 16420203
[TBL] [Abstract][Full Text] [Related]
16. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
Yu H; Dick AW; Szilagyi PG
Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
18. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
[TBL] [Abstract][Full Text] [Related]
19. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
Manley HJ; Cannella CA
Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
[TBL] [Abstract][Full Text] [Related]
20. Generic medications for you, but brand-name medications for me.
Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
